TLL018 extended release
/ Highlightll Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
March 01, 2024
Evaluation of TLL-018 Extended and Immediate Release Formulation for Bioequivalence Testing in Healthy Chinese Subjects
(clinicaltrials.gov)
- P1 | N=28 | Completed | Sponsor: Hangzhou Highlightll Pharmaceutical Co., Ltd | Active, not recruiting ➔ Completed
Trial completion • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
July 14, 2023
Evaluation of TLL-018 Extended and Immediate Release Formulation for Bioequivalence Testing in Healthy Chinese Subjects
(clinicaltrials.gov)
- P1 | N=28 | Active, not recruiting | Sponsor: Hangzhou Highlightll Pharmaceutical Co., Ltd
New P1 trial • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
1 to 2
Of
2
Go to page
1